News
CoreMap today announced it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug ...
Prof Martin Dreyling discusses the safety profile of the BTK inhibitor acalabrutinib in patients with mantle cell lymphoma.
He was rushed to hospital by ambulance on Feb. 22, suffering from cardiac problems. Worthington said he has been bounced ...
Learn to read your pulse for hidden heart problems. Rhythm irregularities and rate changes reveal cardiovascular issues.
Learn critical heart skipping patterns that signal emergency situations. Recognize dangerous rhythm changes that demand ...
A recent study has found that adults hospitalized with respiratory syncytial virus (RSV) infection are more likely to ...
A 46-year-old woman with type 1 myotonic dystrophy (DM1) presented to the emergency department with dyspnea and palpitations.
Purpose. A case of fatal retroperitoneal hematoma that developed after enoxaparin administration in a woman with paroxysmal atrial flutter and chest pain is reported. Summary. A 63-year-old ...
Patients with AF and ACHD that receive NOAC, compared with VKA, for stroke prevention have lower risk of all-cause mortality.
A New Pacemaker Algorithm for the Treatment of Atrial Fibrillation: Results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT) Electrophysiologic Characteristics of the Spontaneous Onset and ...
Cardioversion is a procedure used to treat heart arrhythmias, such as atrial fibrillation (AFib), which occurs when the heart beats too quickly, too slowly, or irregularly. The most common type of ...
Bayer has decided to discontinue a phase 3 trial of its oral Factor XIa inhibitor asundexian in patients with atrial fibrillation (AF), after an interim analysis concluded the novel anticoagulant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results